Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 2
2021 2
2022 1
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Immunotherapy responsiveness and risk of relapse in Down syndrome regression disorder.
Santoro JD, Spinazzi NA, Filipink RA, Hayati-Rezvan P, Kammeyer R, Patel L, Sannar EA, Dwyer L, Banerjee AK, Khoshnood M, Jafarpour S, Boyd NK, Partridge R, Gombolay GY, Christy AL, Real de Asua D, Del Carmen Ortega M, Manning MA, Van Mater H, Worley G, Franklin C, Stanley MA, Brown R, Capone GT, Quinn EA, Rafii MS. Santoro JD, et al. Among authors: del carmen ortega m. Transl Psychiatry. 2023 Aug 8;13(1):276. doi: 10.1038/s41398-023-02579-z. Transl Psychiatry. 2023. PMID: 37553347 Free PMC article.
Lessons from individuals with Down syndrome during COVID-19.
Del Carmen Ortega M, Borrel JM, de Jesús Bermejo T, González-Lamuño D, Manso C, de la Torre R, Mayer MA, de Asúa DR, Dierssen M; Spanish Trisomy 21 Research Society COVID-19 Taskforce. Del Carmen Ortega M, et al. Lancet Neurol. 2020 Dec;19(12):974-975. doi: 10.1016/S1474-4422(20)30401-4. Lancet Neurol. 2020. PMID: 33212059 Free PMC article. No abstract available.
Comparison of COVID-19 and Non-COVID-19 Pneumonia in Down Syndrome.
Real de Asua D, Mayer MA, Ortega MDC, Borrel JM, Bermejo TJ, González-Lamuño D, Manso C, Moldenhauer F, Carmona-Iragui M, Hüls A, Sherman SL, Strydom A, de la Torre R, Dierssen M. Real de Asua D, et al. Among authors: ortega mdc. J Clin Med. 2021 Aug 23;10(16):3748. doi: 10.3390/jcm10163748. J Clin Med. 2021. PMID: 34442043 Free PMC article.
Assessment and Diagnosis of Down Syndrome Regression Disorder: International Expert Consensus.
Santoro JD, Patel L, Kammeyer R, Filipink RA, Gombolay GY, Cardinale KM, Real de Asua D, Zaman S, Santoro SL, Marzouk SM, Khoshnood M, Vogel BN, Tanna R, Pagarkar D, Dhanani S, Ortega MDC, Partridge R, Stanley MA, Sanders JS, Christy A, Sannar EM, Brown R, McCormick AA, Van Mater H, Franklin C, Worley G, Quinn EA, Capone GT, Chicoine B, Skotko BG, Rafii MS. Santoro JD, et al. Among authors: ortega mdc. Front Neurol. 2022 Jul 15;13:940175. doi: 10.3389/fneur.2022.940175. eCollection 2022. Front Neurol. 2022. PMID: 35911905 Free PMC article.
Immunotherapy Responsiveness and Risk of Relapse in Down Syndrome Regression Disorder.
Santoro J, Spinazzi N, Filipink R, Hayati-Rezvan P, Kammeyer R, Patel L, Sannar E, Dwyer L, Banerjee A, Khoshnood M, Jafarpour S, Boyd N, Partridge R, Gombolay G, Christy A, Real de Asua D, Del Carmen Ortega M, Manning M, Van Mater H, Worley G, Franklin C, Stanley M, Brown R, Capone G, Quinn E, Rafii M. Santoro J, et al. Among authors: del carmen ortega m. Res Sq [Preprint]. 2023 Feb 13:rs.3.rs-2521595. doi: 10.21203/rs.3.rs-2521595/v1. Res Sq. 2023. PMID: 36824719 Free PMC article. Updated. Preprint.
An international survey on the impact of COVID-19 in individuals with Down syndrome.
Hüls A, Costa ACS, Dierssen M, Baksh RA, Bargagna S, Baumer NT, Brandão AC, Carfi A, Carmona-Iragui M, Chicoine BA, Ghosh S, Lakhanpaul M, Manso C, Mayer MA, Del Carmen Ortega M, de Asua DR, Rebillat AS, Russell LA, Sgandurra G, Valentini D, Sherman SL, Strydom A. Hüls A, et al. Among authors: del carmen ortega m. medRxiv [Preprint]. 2020 Nov 5:2020.11.03.20225359. doi: 10.1101/2020.11.03.20225359. medRxiv. 2020. PMID: 33173907 Free PMC article. Updated. Preprint.
Medical vulnerability of individuals with Down syndrome to severe COVID-19-data from the Trisomy 21 Research Society and the UK ISARIC4C survey.
Hüls A, Costa ACS, Dierssen M, Baksh RA, Bargagna S, Baumer NT, Brandão AC, Carfi A, Carmona-Iragui M, Chicoine BA, Ghosh S, Lakhanpaul M, Manso C, Mayer MA, Ortega MDC, de Asua DR, Rebillat AS, Russell LA, Sgandurra G, Valentini D, Sherman SL, Strydom A; T21RS COVID-19 Initiative. Hüls A, et al. Among authors: ortega mdc. EClinicalMedicine. 2021 Mar;33:100769. doi: 10.1016/j.eclinm.2021.100769. Epub 2021 Feb 22. EClinicalMedicine. 2021. PMID: 33644721 Free PMC article.